Use of nicotinamide riboside to treat hearing loss
AssigneeCornell University
InventorsKevin Brown, Anthony Sauve, Samie Jaffrey
Life of this patent
Estimating the term…
Abstract
The invention provides a method of preventing or treating hearing loss in a mammal in need thereof. The method involves administering to the mammal an agent that increases intracellular NAD+ in the mammal. The invention also provides a method of determining if a compound acts as a neuroprotective agent.
Claims19
A method of preventing, mitigating, or treating hearing loss in a mammal in need thereof, comprising administering to the mammal an effective amount of an agent that increases intracellular NAD+ in the mammal, thereby preventing or treating hearing loss in the mammal.
A method of determining if an agent acts as a hearing protective agent, comprising (a) providing a mammal, (b) administering the agent to the mammal, (c) exposing the mammal to noise, and (d) determining the level of NAD+ in hearing-related cells of the mammal, thereby determining if the agent acts as a neuroprotective agent based on the level of NAD+ in hearing-related cells of the mammal.
(canceled)
Dependencies are inferred from the claim text.